Emily Rollins - 08 May 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role: Director
Signature: /s/ Daniel Rodriguez, as Attorney-in-Fact for Emily Rollins
Issuer symbol: DLB
Transactions as of: 08 May 2023
Net transactions value: -$84,700
Form type: 4
Filing time: 10 May 2023, 16:50:41 UTC
Previous filing: 23 Mar 2023
Next filing: 12 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DLB	Class A Common Stock	Sale	$84,700	-1,000	-15%	$84.70	5,541	08 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held following the reported transaction include 3,296 restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 8, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.